Abstract: Vilsmeier formylation of 2-(1-phenylhydrazonoethyl)naphtho [2,1-b]furan (2) gave 3-naphtho[2,1-b]furan-2-yl-1-phenyl-1H-pyrazole-4-carbaldehyde (3), which was reacted with C-and N-nucleophiles to afford naphthofuranpyrazol derivatives 4-8. Treatment of 2- [(3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl)methylene]-malononitrile (4a) with reactants having active hydrogen and Et 3 N gave the corresponding pyrazoline, pyran and chromene addition product derivatives 10, 12 and 13, consisting of three different connected heterocyclic moieties. Reaction of 1-((3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl) methylene)-2-phenylhydrazone (6b) with AcONa and ethyl bromoacetate or chloroacetone afforded the thiazolidinone and methylthiazole derivatives 14 and 15, respectively. In addition, intramolecular cyclization of 6d with Ac 2 O afford the corresponding 1,3,4-thiadiazol-2-yl acetamide derivative 16. The structures of the synthesized compounds were confirmed by IR, 1 H-NMR/ 13 C-NMR and mass spectral studies. Compound 14 showed promising effects against the tested Gram positive and negative bacteria and fungi.
Introduction
Naphthofuran derivatives exhibit very potent antibacterial [1] [2] [3] , genotoxic [4] [5] [6] and anticancer activity [7] [8] [9] , but some were shown to be mutagenic in bacteria [10] [11] [12] [13] [14] [15] . The present investigation deals with the synthesis of some new naphtho [2,1-b] furan derivatives bearing pyrazole nuclei attached to different heterocyclic moieties and their biological activities.
Results and Discussion
Condensation of 2-acetylnaphtho[2,1-b]furan (1) [16] with phenylhydrazine afforded 2-(1-phenylhydrazonoethyl)naphtho [2,1-b] furan (2) . Vilsmeier formylation [17] of the latter afforded 3-(naphtho-[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazole-4-carboxaldehyde (3) . Condensation of 3 with a variety of C-nucleophiles, namely malononitrile, cyanoacetamide, cyanothioacetamide, barbituric acid and 2-acetylnaphtho [2,1-b] furan (1) give the condensation products 4, 5 and 8, while reactions with Nnucleophiles, namely hydrazine derivatives or amines, afforded the condensation products 6 and 7 (Scheme 1). Compounds 4a and 6d were used as key intermediates in the synthesis of novel pyran, pyrazole and thiazole derivatives via their interaction with different reagents. Thus, the reaction of 4a with 3-methyl-1-phenyl-2-pyrazolin-5-one in the presence of triethylamine did not give the expected pyrazolopyran 9 and instead, only one compound was isolated, identified as 4-[3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl]methylene-3-methyl-1-phenyl-2-pyrazoline-5-one (10), while with hydrazine hydrate in refluxing ethanol it furnished 6a (as verified by m.p. and mixed m.p.) instead of the pyrazole derivative 11. The formation of 6a and 10 were assumed to proceed via elimination of malononitrile [18] and their structures were further confirmed by independent synthesis via direct condensation of 3 with hydrazine hydrate (Scheme 1) or with 3-methyl-1-phenyl-2-pyrazolin-5-one (Scheme 2), respectively The reaction of 4a with ethyl acetoacetate in dry methylene chloride containing triethylamine gave the pyrazolopyran derivative 12, while with 4-hydroxycoumarin under Michael reaction conditions it afforded the 4H-pyran derivative 13 (Scheme 2). The structure of 13 was further verified by m.p. and mixed m.p after independent synthesis via direct condensation of 3 with 4-hydroxycoumarin in the presence of malononitrile and a few drops of piperidine as a base (a one pot reaction). When thiosemicarbazone derivative 6d was allowed to react with ethyl bromoacetate or chloroacetone in the presence of fused sodium acetate, it gave the corresponding thiazolidinone and thiazoline derivatives 14 and 15, respectively, while with refluxing acetic anhydride it afforded the thiadiazole derivative 16 (Scheme 2). These reactions were assumed to proceed via S-alkylation followed by intramolecular cyclization with concomitant loss of an alcohol molecule and/or dehydration.
Structures 2, 3, 4, 5, 6, 7 and 8 were established by spectral and physical data (Tables I-II 494 (100) 310 (2) 193 (5) 139 (8) 77 (31) 466 (2), 386 (25), 233 (4) 12 516 (2) 193 (13) 139 (5) 77 (16) Structures 10, 11, 12, 13, and 16 were established by spectral data (Tables I-II 4a-c, 5, 6, 7a,b, 8a-c, 10, 12, 13 showed no activities against any of the test microorganisms.
Experimental

General
Melting points were measured on a Stuart Scientific Co (UK) melting point apparatus and are uncorrected. The IR spectra were recorded on a Shimadzu IR 440, spectrophotometer (Shimadzu, Japan) in KBr. The 1 H-NMR/ 13 C-NMR spectra were measured on a Varian Mercury (300 MHz) spectrometer (Varian, UK), using TMS as an internal standard and DMSO-d 6 as solvent. Mass spectra were run on a Shimadzu GC-Ms QP 1000 EX mass spectrometer. Microanalytical data were obtained from the Microanalytical Unit Center, Faculty of Science, Cairo University (Egypt). Spectral and microanalytical data are given in Tables I-III . The paper discs were manufactured by Bristol-Myers Squibb, Giza, Egypt. 
Synthesis of 3-naphtho[2,1-b]furan-2-yl-1-phenyl-1H-pyrazole-4-carbaldehyde (3):
To ice cold dimethylformamide (0.01 mol) was added dropwise with stirring phosphorus oxychloride (0.01 mol) over a period of 30 min. stirring was continued for further 45 min keeping the reaction mixture at 0 °C. The hydrazone 2 (3 g, 0.01 mol) was then added and the reaction mixture was allowed to attain room temperature. The mixture was heated at 90 °C for 2 h, allowed to cool and poured onto crushed ice (50 gm) and water (100 mL), the solid product that was formed was filtered off and washed with water and recrystallized from EtOH to give 3 (70% yield) 
Synthesis of 2-((3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl)methylene) malononitrile (4a), 2-cyano-3-(3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl) acrylamide (4b) and 2-cyano-3-(3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl) prop-2-enethioamide
Synthesis of 5-((3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl) methylene) pyrimidine-2,4,6(1H,3H,5H)trione
Synthesis of 1-((3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl)methylene) hydrazone
A mixture of aldehyde 3 (3.38 g, 0.01 mol) and hydrazine hydrate, phenyl hydrazine, acetylhydrazine, thiosemicarbazide or cyanoacetic acid hydrazide (0.01 mol) in ethanol (30 mL) was refluxed for 3 h, the solid separated on heating was filtered off and recrystallized from a suitable solvent to give 6a-e (75-80 %). 6a: IR: 3,400, 3,364 (NH 2 ), 1,598 (C=N), 1 ( (12) : To a solution of 4a (0.01 mol) and ethyl acetoacetate (0.01 mol) in methylene chloride (50 mL), triethylamine (0.01 mL) was added. The mixture was heated under reflux for 4 h, concentrated and allowed to cool. The precipitated product was collected and recrystallized from ethanol to give 12 (70 % yield 
Synthesis of 1-(naphtho
[2,1-b]furan-2-yl)-3-(3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4- yl)prop-2-en-1-one (8):
Synthesis of 4-[3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl]methylene-3-methyl-1-phenyl-2-pyrazoline-5-one
Synthesis of ethyl 6-amino-5-cyano-2-methyl-4-(3-(naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl)-4H-pyran-3-carboxylate
Synthesis of 3-amino-
To a solution of 4a (0.01 mol) and 4-hydroxycoumarin (0.01mol) in ethanol (50 mL) a few drops of piperidine (0.01 mL) were added. The mixture was heated under reflux for 4h and allowed to cool. The precipitated product was collected and recrystallized from dioxane to give 13 (70% yield 
Antibacterial activity
The newly synthesized compounds were screened for their antimicrobial activities in vitro against two species of Gram-positive bacteria Bacillus subtilis (NCTC-10400)(BS), Staphylococcus aureus (NCTC 7447)(SA), and three Gram-negative bacteria, Escherichia coli (NCTC 10410)(EC), Pseudomonas aeruginosa (ATCC 10415)(PA), Candida albicans (IMRU 3669)(CA), and one fungus, Aspergillus niger (ATCC 6275)(AN). The activities of these compounds were tested using the disc diffusion method [19, 20] . The area of zone of inhibition was measured using neomycin (30 µg mL -1 ) as standard antibiotic (Table III) . The tested compounds were dissolved in N,Ndimethylformamide (DMF) to give a solution of 1 mg mL −1 . The inhibition zones were measured in millimeters at the end of an incubation period of 48 h at 28 °C. N,N-dimethylformamide (DMF) showed no inhibition zone.
Conclusions
A series of novel naphtho[2,1-b]furan pyrazole derivatives were prepared. The antimicrobial activity of these compounds was evaluated against various Gram-positive, Gram-negative bacteria and fungi. 2-[(3-Naphtho[2,1-b]furan-2-yl)-1-phenyl-1H-pyrazol-4-yl]methylenehydrazonothiazolidin-4-one (14) showed the highest antibacterial activity, while compound 2 showed moderate activity, and the remaining tested compounds 4a-c, 5, 6, 7a,b, 8a-c, 10, 12, 13 showed no activities against any of the test microorganisms.
